Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Balance Sheet

Financials in millions GHS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.06	1.49	0.29	0.95	0.81	0.96
Cash & Short-Term Investments	1.06	1.49	0.29	0.95	0.81	0.96
Cash Growth	96.02%	405.98%	-69.17%	18.07%	-16.05%	41.03%
Accounts Receivable	11.56	10.23	15.07	15.13	15.74	14.17
Other Receivables	-	2.41	1.44	1.77	1.79	2.21
Receivables	11.56	12.63	16.51	16.9	17.53	16.37
Inventory	5.04	6.09	6.26	6.63	7.65	6.06
Prepaid Expenses	-	0.06	0.09	0.07	0.09	0.08
Total Current Assets	17.65	20.26	23.15	24.55	26.08	23.48
Property, Plant & Equipment	24.27	24.5	23.26	22.21	20.41	13.79
Long-Term Investments	0.01	0.01	0.01	-	-	-
Other Intangible Assets	-	0.07	0.07	0.06	0.06	0.06
Other Long-Term Assets	-0.01	-	-	-	-	-
Total Assets	41.92	44.84	46.49	46.82	46.55	37.33
Accounts Payable	17.19	12.21	9.33	8.52	7.1	3.62
Accrued Expenses	-	0.05	0.18	0.18	0.2	0.29
Short-Term Debt	-	0.87	1.23	1.64	-	-
Current Portion of Long-Term Debt	3.94	3.94	3.94	4.09	2.54	3.87
Current Portion of Leases	-	0.01	0.02	0.02	0.01	0.01
Current Income Taxes Payable	-	-	0	-	-	-
Other Current Liabilities	-	7.31	6.15	6.96	4.15	3.08
Total Current Liabilities	21.14	24.4	20.86	21.4	14	10.87
Long-Term Debt	4.32	3.94	7.88	10.36	13.81	8.06
Long-Term Leases	0.03	0.03	0.03	0.03	0.03	0.03
Long-Term Deferred Tax Liabilities	0.55	0.55	0.39	0.25	0.41	0.42
Total Liabilities	26.04	28.93	29.17	32.04	28.26	19.39
Common Stock	11.63	11.63	11.63	11.63	11.63	11.63
Additional Paid-In Capital	2.1	2.1	2.1	2.1	2.1	2.1
Retained Earnings	2.15	2.18	3.59	1.05	4.56	4.21
Shareholders' Equity	15.88	15.91	17.32	14.78	18.29	17.94
Total Liabilities & Equity	41.92	44.84	46.49	46.82	46.55	37.33
Total Debt	8.3	8.81	13.12	16.13	16.39	11.97
Net Cash (Debt)	-7.24	-7.32	-12.83	-15.18	-15.58	-11.01
Net Cash Per Share	-0.03	-0.03	-0.05	-0.06	-0.06	-0.04
Filing Date Shares Outstanding	267.38	274.41	274.41	274.41	274.41	274.41
Total Common Shares Outstanding	267.38	274.41	274.41	274.41	274.41	274.41
Working Capital	-3.48	-4.14	2.29	3.15	12.08	12.61
Book Value Per Share	0.06	0.06	0.06	0.05	0.07	0.07
Tangible Book Value	15.88	15.84	17.25	14.72	18.23	17.88
Tangible Book Value Per Share	0.06	0.06	0.06	0.05	0.07	0.07
Land	-	3.74	3.74	3.74	2.66	2.66
Machinery	-	8.79	8.74	5.59	5.48	5.37
Construction In Progress	-	18.12	16.31	17.63	16.41	9.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.